Renal Cancer - Results from #5260

First-line sunitinib or pazopanib in metastatic renal cell carcinoma: The Canadian experience May 23, 2017

Assessment of nivolumab benefit-risk profile of a 240-mg flat dose relative to a 3-mg/kg dosing regimen in patients with advanced tumors May 22, 2017

Analysis of healthy and tumour DNA methylation distributions in kidney-renal-clear-cell-carcinoma using Kullback-Leibler and Jensen-Shannon distance measures May 22, 2017

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors May 12, 2017

Managing Renal Cell Carcinoma Associated Paraneoplastic Syndrome with Nephron-sparing Surgery in a Patient with von Hippel-Lindau May 11, 2017

Risk models for patients with localised renal cell carcinoma May 11, 2017

The long noncoding RNA urothelial carcinoma-associated 1 overexpression as a poor prognostic biomarker in clear cell renal cell carcinoma May 10, 2017

Ultrasound-guided percutaneous radiofrequency ablation for treating small renal masses May 10, 2017

Impressive and durable response to nivolumab in a patient with metastatic type 2 papillary renal cell carcinoma: On-label but without evidence May 9, 2017

Prognostic significance of PD-L1 in solid tumor: An updated meta-analysis. May 9, 2017

An Immune Atlas of Clear Cell Renal Cell Carcinoma. May 8, 2017

Optimum outcome achievement in partial nephrectomy for T1 renal masses: a contemporary analysis of open and robot-assisted cases. May 4, 2017

Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma May 3, 2017

Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases May 3, 2017

The utility of axial abdominal imaging after partial nephrectomy for T1 renal cell carcinoma surveillance May 2, 2017

Clear cell sarcoma of kidney involving a horseshoe kidney and harboring EGFR internal tandem duplication May 2, 2017

Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy May 1, 2017

Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate May 1, 2017

Trends in the surgical management of Stage 1 Renal Cell Carcinoma: findings from a population-based study April 30, 2017

Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma April 30, 2017

Page 264 of 460